Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Prevention: Lowering your Risk

Cancer Prognosis

CDK9 and Cancer

Why are Cancer Cell Lines Useful?

Living with Cancer Pain

Hypoxia Markers and Their Importance

Is Cancer a Metabolic Disorder?

Cancer History

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Acidosis and Tumor Progression

What Causes Cancer?

See more featured articles »

Insights into Oncofertility

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Insight into Cancer Vaccines

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

What is Immunochemotherapy?

Secondary Brain Cancer

Using Biomarkers to Detect Cancer

Cancer Epidemiology

What is Cancer?

What Role do Biobanks Play in Cancer Research?

Cancer Research

Cancer Screening Considerations: Balancing the Benefits and Risks

What is Tumorigenesis?

Cancer Glossary

Cancer Pain Management

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer Diagnosis

Hot vs Cold: the differences between tumor types

Transforming Cancer Care through Genomic Testing

Secondary Lung Cancer

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer Classification

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

The Cancer Cell Surface Proteome as a Therapeutic Target

Assay for Monitoring and Treating Malignant Brain Tumors

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Cutaneous Manifestations of Internal Malignancy

Cancer Symptoms

Metastatic Migration in Cancer may be Influenced by Metabolism

Cancer Pain

Cancer Pathophysiology

TARDIS: The Improved Method of Detecting Breast Cancer

What is Merkel Cell Carcinoma?

Targeted Cancer Therapies

What is the Tumor Microenvironment?

Myc Mutations and Cancer

The Biochemistry of Breast Cancer Screening

Pediatric Cancer

Microfluidic cancer treatment screen combined with flow cytometry

Caring for a Loved One with Cancer

Exploiting Enzymes in Cancer Diagnosis and Therapy

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

The Effects of Cancer on Family Life

Cancer Management

Investigating the Molecular Mechanisms of Cancer

Effects of Social and Economic Deprivation on Cancer Mortality

Overview of Cell Viability and Cytotoxicity

What is Cancer of Unknown Primary?

British Pioneers in Cancer Biology

Latest Cancer News and Research

BeOne Medicines announces voluntary agreement with U.S. Government to expand access to innovative cancer medicines

BeOne Medicines, Ltd., a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S manufacturing footprint and further expanding the capabilities needed to deliver medicines at scale.

1 Sep 2026

Early-onset bowel cancer shows distinct biological and clinical features

One of Australia's largest real world studies of younger adults with advanced bowel cancer has identified important differences between cancers diagnosed before and after the age of 50, which could help doctors tailor treatments for younger adults more effectively.

1 Sep 2026

Social media messages could empower parents to prevent teen vaping

Parents are an important line of defense against teen vaping, yet many lack the knowledge and tools needed to recognize vaping products, understand their risks and prevent their children from using them.

31 Aug 2026

AI tools map tumor architecture to predict treatment response

Spatial transcriptomics is a powerful tool to create a detailed map of not just how genes are expressed in a piece of tissue, but also where genetic activity takes place in different cells and locations within the tissue.

31 Aug 2026

Multimorbidity linked to shorter lifespans in aging dogs

As dogs age, many develop more than one chronic health condition. New research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences (VMBS) shows those conditions can dramatically shorten a dog's lifespan, highlighting the importance of managing multiple diseases together rather than individually.

31 Aug 2026

New ASICA app helps melanoma survivors check their skin

Researchers behind an app designed to support people after skin cancer treatment are inviting former early-stage melanoma patients to take part in its final evaluation tests.

31 Aug 2026

New dual-drug strategy blocks triple-negative breast cancer growth

Triple-negative breast cancer (TNBC) has a frustrating ability to adapt. Although this aggressive form of breast cancer can initially respond well to chemotherapy, cancer cells often find ways to survive, allowing the disease to return and become resistant to treatment.

31 Aug 2026

Routine referral of prostate cancer patients to a cardiovascular specialist fails to cut cardiac events

Men with prostate cancer have a high risk of heart disease, especially when treated with hormone therapy.

31 Aug 2026

UC San Diego researchers win DARPA award to develop improved red blood cells

Researchers at the University of California San Diego School of Medicine have been awarded a contract of up to $11.312 million from the Defense Advanced Research Projects Agency (DARPA) to pursue a high-risk, high-reward research project aimed at developing optimized red blood cells that can temporarily boost human performance and health.

31 Aug 2026

Newly discovered lung immune cells could transform future flu vaccine design

Influenza continues to cause major illness each year in the United States, leading to more than 35,000 deaths annually. Children, older adults, pregnant individuals, people with weakened immune systems, and those with chronic conditions such as heart disease, metabolic disorders, and cancer are especially vulnerable.

31 Aug 2026

Your skin may offer clues about how many fruits and vegetables you eat

In an exploratory study of 137 Australian adults, skin yellowness measured by reflectance spectroscopy was associated with combined fruit and vegetable intake, fruit intake alone, total carotenoid intake, body fat percentage and skin color. The findings suggest skin measurements could provide an objective dietary biomarker, but the researchers caution that skin color, ethnicity and other individual characteristics may influence how the measurements are interpreted.

30 Aug 2026

Breast cancer survivors could avoid lifelong heart medication, research suggests

Many breast cancer survivors whose treatment caused them to develop problems with their heart function can safely stop their medication after their heart recovers and most won't need to continue treatment long-term, according to a study funded by the British Heart Foundation and presented at the European Society of Cardiology Congress in Munich.

30 Aug 2026

FDA approves daraxonrasib for patients with metastatic pancreatic cancer

The U.S. Food and Drug Administration (FDA) has approved daraxonrasib for patients whose pancreatic cancer has spread to other parts of the body and continued to progress despite previous treatment.

29 Aug 2026

FDA approves daraxonrasib for metastatic pancreatic cancer following landmark clinical trial led by Dana-Farber

The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or are not candidates for multiagent systemic therapy.

From Dana-Farber Cancer Institute, Inc. 29 Aug 2026